$ASPX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Auspex Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Auspex Pharmaceuticals, Inc.. Get notifications about new insider transactions in Auspex Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 0.86 | 401,850 | 346,395 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 3.88 | 167,883 | 651,218 | 167,883 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 0.86 | 755,478 | 651,222 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 3.88 | 58,667 | 227,569 | 58,667 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 0.86 | 264,003 | 227,571 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 3.88 | 59,532 | 230,925 | 59,532 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 0.86 | 267,899 | 230,929 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 3.88 | 65,161 | 252,760 | 65,161 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 0.86 | 293,230 | 252,764 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 0.00 | 1,106,779 | 0 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 0.00 | 11,792,529 | 0 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 0.00 | 7,474,419 | 0 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 0.00 | 2,266,186 | 0 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Buy | P | 12.00 | 82,475 | 989,700 | 5,113,567 | 5 M to 5.1 M (+1.64 %) |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Buy | C | 0.00 | 5,031,092 | 0 | 5,031,092 | 0 to 5 M |
Sep 22 2014 | ASPX | Auspex Pharmaceuti ... | PROEHL GERALD T | Director | Buy | P | 21.75 | 1,466 | 31,885 | 1,466 | 0 to 1.5 K |
Sep 11 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | S | 0.00 | 1 | 0 | 1 | |
Sep 11 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | P | 0.00 | 1 | 0 | 1 | |
Sep 11 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | S | 0.00 | 1 | 0 | 1 | |
Sep 11 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | P | 0.00 | 1 | 0 | 1 | |
Sep 09 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | X | 3.88 | 65,839 | 255,389 | 0 | |
Sep 09 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Sell | S | 20.60 | 12,400 | 255,415 | 5,220,224 | 5.2 M to 5.2 M (-0.24 %) |
Sep 09 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Buy | X | 3.88 | 65,839 | 255,389 | 5,232,624 | 5.2 M to 5.2 M (+1.27 %) |
Sep 09 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | X | 3.88 | 65,839 | 255,389 | 0 | |
Sep 09 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Sell | S | 20.60 | 12,400 | 255,415 | 5,220,224 | 5.2 M to 5.2 M (-0.24 %) |
Sep 09 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Buy | X | 3.88 | 65,839 | 255,389 | 5,232,624 | 5.2 M to 5.2 M (+1.27 %) |
Sep 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 23.50 | 222 | 5,217 | 95,469 | 95.7 K to 95.5 K (-0.23 %) |
Sep 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 23.50 | 8,678 | 203,926 | 3,721,288 | 3.7 M to 3.7 M (-0.23 %) |
Sep 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 24.05 | 417 | 10,030 | 95,691 | 96.1 K to 95.7 K (-0.43 %) |
Sep 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 24.05 | 16,283 | 391,634 | 3,729,966 | 3.7 M to 3.7 M (-0.43 %) |
Sep 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | X | 3.88 | 1,175 | 4,558 | 0 | |
Sep 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | X | 3.88 | 45,853 | 177,864 | 0 | |
Sep 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | X | 3.88 | 1,175 | 4,558 | 97,966 | 96.8 K to 98 K (+1.21 %) |
Sep 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | X | 3.88 | 45,853 | 177,864 | 3,818,791 | 3.8 M to 3.8 M (+1.22 %) |
Sep 04 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 23.09 | 312 | 7,205 | 94,933 | 95.2 K to 94.9 K (-0.33 %) |
Sep 04 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 23.09 | 12,188 | 281,467 | 3,700,396 | 3.7 M to 3.7 M (-0.33 %) |
Sep 04 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 23.07 | 255 | 5,883 | 95,245 | 95.5 K to 95.2 K (-0.27 %) |
Sep 04 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 23.07 | 9,945 | 229,425 | 3,712,584 | 3.7 M to 3.7 M (-0.27 %) |
Sep 03 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 22.59 | 217 | 4,903 | 95,500 | 95.7 K to 95.5 K (-0.23 %) |
Sep 03 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 22.59 | 8,483 | 191,650 | 3,722,529 | 3.7 M to 3.7 M (-0.23 %) |
Aug 28 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 21.35 | 157 | 3,352 | 96,457 | 96.6 K to 96.5 K (-0.16 %) |
Aug 28 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 21.35 | 6,143 | 131,165 | 3,759,872 | 3.8 M to 3.8 M (-0.16 %) |
Aug 29 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 22.24 | 305 | 6,784 | 95,717 | 96 K to 95.7 K (-0.32 %) |
Aug 29 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 22.24 | 11,895 | 264,564 | 3,731,012 | 3.7 M to 3.7 M (-0.32 %) |
Aug 29 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 21.88 | 435 | 9,517 | 96,022 | 96.5 K to 96 K (-0.45 %) |
Aug 29 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 21.88 | 16,965 | 371,148 | 3,742,907 | 3.8 M to 3.7 M (-0.45 %) |
Aug 27 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 20.81 | 135 | 2,809 | 96,614 | 96.7 K to 96.6 K (-0.14 %) |
Aug 27 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 20.81 | 5,265 | 109,549 | 3,766,015 | 3.8 M to 3.8 M (-0.14 %) |
Aug 26 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 20.56 | 42 | 863 | 96,749 | 96.8 K to 96.7 K (-0.04 %) |
Aug 26 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 20.56 | 1,658 | 34,085 | 3,771,280 | 3.8 M to 3.8 M (-0.04 %) |
Jul 16 2014 | ASPX | Auspex Pharmaceuti ... | GREER R SCOTT | Director | Buy | P | 19.25 | 5,190 | 99,908 | 7,190 | 2 K to 7.2 K (+259.50 %) |
Jul 16 2014 | ASPX | Auspex Pharmaceuti ... | CHOWRIRA BHARAT M | Chief Operating Off ... | Buy | P | 19.25 | 5,190 | 99,908 | 6,084 | 894 to 6.1 K (+580.54 %) |
May 07 2014 | ASPX | Auspex Pharmaceuti ... | GREER R SCOTT | Director | Option Exercise | A | 18.13 | 20,000 | 362,600 | 20,000 | |
May 07 2014 | ASPX | Auspex Pharmaceuti ... | Bleil Lynn Dorsey | Director | Option Exercise | A | 18.13 | 20,000 | 362,600 | 20,000 | |
May 07 2014 | ASPX | Auspex Pharmaceuti ... | PROEHL GERALD T | Director | Option Exercise | A | 18.13 | 6,667 | 120,873 | 6,667 | |
May 07 2014 | ASPX | Auspex Pharmaceuti ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 18.13 | 6,667 | 120,873 | 6,667 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 3.88 | 90,228 | 349,994 | 90,228 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 0.86 | 406,032 | 350,000 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 3.88 | 169,630 | 657,995 | 169,630 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 0.86 | 763,340 | 657,999 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 3.88 | 59,277 | 229,935 | 59,277 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 0.86 | 266,750 | 229,939 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 3.88 | 60,151 | 233,326 | 60,151 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 0.86 | 270,687 | 233,332 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 3.88 | 65,839 | 255,389 | 65,839 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 0.86 | 296,281 | 255,394 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 0.00 | 1,118,298 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 0.00 | 11,915,254 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 0.00 | 7,552,207 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Option Exercise | C | 0.00 | 2,289,771 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Buy | P | 12.00 | 83,334 | 1,000,008 | 5,166,785 | 5.1 M to 5.2 M (+1.64 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | 10% Owner | Buy | C | 0.00 | 5,083,451 | 0 | 5,083,451 | 0 to 5.1 M |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 3.88 | 90,228 | 349,994 | 90,228 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 0.86 | 406,032 | 350,000 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 3.88 | 169,630 | 657,995 | 169,630 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 0.86 | 763,340 | 657,999 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 3.88 | 59,277 | 229,935 | 59,277 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 0.86 | 266,750 | 229,939 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 3.88 | 60,151 | 233,326 | 60,151 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 0.86 | 270,687 | 233,332 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 3.88 | 65,839 | 255,389 | 65,839 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 0.86 | 296,281 | 255,394 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 0.00 | 1,118,298 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 0.00 | 11,915,254 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 0.00 | 7,552,207 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | C | 0.00 | 2,289,771 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Buy | P | 12.00 | 83,334 | 1,000,008 | 5,166,785 | 5.1 M to 5.2 M (+1.64 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Buy | C | 0.00 | 5,083,451 | 0 | 5,083,451 | 0 to 5.1 M |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 3.88 | 64,449 | 249,998 | 64,449 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 0.86 | 290,022 | 249,999 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 3.88 | 121,165 | 469,999 | 121,165 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 0.86 | 545,243 | 469,999 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 3.88 | 42,340 | 164,237 | 42,340 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 0.86 | 190,535 | 164,241 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 3.88 | 42,966 | 166,665 | 42,966 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 0.86 | 193,348 | 166,666 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 3.88 | 47,028 | 182,422 | 47,028 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 0.86 | 211,629 | 182,424 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 0.00 | 1,397,873 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 0.00 | 8,510,898 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 0.00 | 5,394,437 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | C | 0.00 | 1,635,551 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | P | 12.00 | 2,688 | 32,256 | 96,796 | 94.1 K to 96.8 K (+2.86 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | C | 0.00 | 94,103 | 0 | 94,103 | 0 to 94.1 K |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | P | 12.00 | 102,873 | 1,234,476 | 3,772,938 | 3.7 M to 3.8 M (+2.80 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | C | 0.00 | 3,670,065 | 0 | 3,670,065 | 0 to 3.7 M |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Panorama Capital, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,266,952 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Panorama Capital, L.P. | 10% Owner | Option Exercise | C | 0.00 | 8,700,698 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Panorama Capital, L.P. | 10% Owner | Buy | P | 12.00 | 333,334 | 4,000,008 | 2,770,589 | 2.4 M to 2.8 M (+13.68 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Panorama Capital, L.P. | 10% Owner | Buy | C | 0.00 | 2,437,255 | 0 | 2,437,255 | 0 to 2.4 M |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | FERGUSON RODNEY A | Director | Option Exercise | C | 0.00 | 2,266,952 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | FERGUSON RODNEY A | Director | Option Exercise | C | 0.00 | 8,700,698 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | FERGUSON RODNEY A | Director | Buy | P | 12.00 | 333,334 | 4,000,008 | 2,770,589 | 2.4 M to 2.8 M (+13.68 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | FERGUSON RODNEY A | Director | Buy | C | 0.00 | 2,437,255 | 0 | 2,437,255 | 0 to 2.4 M |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 293,589 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 445,363 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 40,501 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 596,976 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 132,654 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 208,815 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 107,911 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 13,156 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 64,521 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 72,915 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 152,572 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Option Exercise | C | 0.00 | 140,875 | 0 | 0 | |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Buy | C | 0.00 | 65,242 | 0 | 65,242 | 0 to 65.2 K |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Buy | P | 12.00 | 67,263 | 807,156 | 307,894 | 240.6 K to 307.9 K (+27.95 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Buy | C | 0.00 | 240,631 | 0 | 24,061 | -216,570 to 24.1 K (-111.11 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Buy | C | 0.00 | 198,537 | 0 | 226,314 | 27.8 K to 226.3 K (+714.75 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Saks Samuel R | Chief Development O ... | Buy | P | 12.00 | 2,175 | 26,100 | 63,839 | 61.7 K to 63.8 K (+3.53 %) |
Feb 12 2014 | ASPX | Auspex Pharmaceuti ... | Shah Pratik | President and CEO | Buy | P | 12.00 | 8,333 | 99,996 | 903,018 | 894.7 K to 903 K (+0.93 %) |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 2,323,086 | 0 | 0 | |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 2,027,262 | 0 | 0 | |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 654,002 | 0 | 0 | |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 796,114 | 0 | 0 | |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 280,350 | 3,364,200 | 796,591 | 516.2 K to 796.6 K (+54.31 %) |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 244,650 | 2,935,800 | 695,152 | 450.5 K to 695.2 K (+54.31 %) |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 78,400 | 940,800 | 223,733 | 145.3 K to 223.7 K (+53.95 %) |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 96,600 | 1,159,200 | 273,514 | 176.9 K to 273.5 K (+54.60 %) |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 516,241 | 0 | 796,591 | 280.4 K to 796.6 K (+184.14 %) |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 450,502 | 0 | 695,152 | 244.7 K to 695.2 K (+184.14 %) |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 145,333 | 0 | 223,733 | 78.4 K to 223.7 K (+185.37 %) |
Feb 11 2014 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 176,914 | 0 | 273,514 | 96.6 K to 273.5 K (+183.14 %) |